期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肿瘤干细胞的靶向治疗策略 被引量：8

Strategies of targeting cancer stem cell to treat malignant tumors
下载PDF
导出
摘要 肿瘤干细胞理论的提出为恶性肿瘤的治疗提供了新思路。肿瘤干细胞的靶向治疗策略主要包括针对肿瘤干细胞的特异表面标志;针对肿瘤干细胞的信号转导路径;诱导肿瘤干细胞分化;改变肿瘤干细胞的微环境。文中就肿瘤干细胞的靶向治疗策略作一综述。 The theory of cancer stem cell has opened a new perspective for the treatment of malignant tumors. And there are four ways to target cancer stem cell to treat malignant tumors ： act on specific surface markers of the cancer stem cell, affect the signal transduetion pathway of the cancer stem cell, induce the cancer stem cell and change the micro-environment of the cancer stem cell.
作者 曹棉富 周代君 栾嘉 王清良
机构地区 第三军医大学学员旅 <第三军医大学学报>编辑部 西南医院病理研究所
出处 《医学研究生学报》 CAS 北大核心 2012年第8期886-888,共3页 Journal of Medical Postgraduates
关键词 恶性肿瘤 肿瘤干细胞 靶向治疗 Cancer Cancer stem cell Targeted therapy
分类号 R730 [医药卫生—肿瘤]
  • 相关文献

参考文献27

  • 1Mackillop WJ, Ciampi A, Till JE, et al. A stem cell model of human tumor growth: implications for tumor cell clonogenic as- says[J]. Nat Cancer Inst, 1983, 70(1) : 9-16.
  • 2Pim D, Massimi P, Dilworth SM, et al. Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A [ J ]. Oncogene, 2005, 24(53) : 7830-7838.
  • 3孙芬芬,叶小群.肿瘤干细胞耐药机制及对策[J].重庆医学,2010,39(5):540-542. 被引量：3
  • 4Clayton S, Mousa SA. Therapeutics formulated to target cancer stem cells: Is it in our future? [J] Cancer Cell Int, 2011, 11 : 7.
  • 5Tang C, Ang BT, Pervaiz S. Cancer stem cell: target for anti- cancer therapy [ J ]. FASEB 3, 2007, 21 (14) :3777-3785.
  • 6ten Care B, de Bruyn M, Wei Y, et al. Targeted elimination of leukemia stem ceils; a new therapeutic approach in hemato-on- cology[J]. Curr Drug Targets, 2010, 11(i) : 95-110.
  • 7Li C, I-Ieidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells[ J]. Cancer Res, 2007, 67(3) : 1030-1037.
  • 8刘冲,石群立.卵巢癌免疫标记物研究进展[J].医学研究生学报,2010,23(9):985-988. 被引量：14
  • 9Yang ZF, Ho DW, Ng MN, et al. Significance of CD90 + cancer stem cells in human liver cancer[J]. Cancer Cell, 2008, 13 (2) : 153-166.
  • 10Suetsugu A, Nagaki M, Aoki H, et al. Characterization of CD133 + hepatoceUular carcinoma ceils as cancer stem/progenitor cells [ J]. Biochem Biophys Res Commun, 2006, 351 (4) : 820-824.

二级参考文献84

  • 1刘琦,吴波,姜少军,孟奎,石群立,施正良.全反式维甲酸对卵巢上皮性癌荷瘤鼠干预后肿瘤细胞的超微结构变化[J].电子显微学报,2005,24(6):584-589. 被引量：11
  • 2刘锴颉,谭文华,胡雪芬.Ki-67和CD44v5在卵巢癌中的表达和临床意义[J].中国优生与遗传杂志,2007,15(4):36-37. 被引量：2
  • 3鞠晓芳,安铁洙,滕春波.干细胞巢研究进展[J].生理科学进展,2007,38(3):213-218. 被引量：4
  • 4Bast RC,Klug TL,St John E,et al.A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer[J].N Engl J Med,1983,309(15):883-887.
  • 5Hogdall E.Cancer antigen 125 and prognosis[J].Curr Opin Obstet Gynecol,2008,20(1):4-8.
  • 6Nagele F,Petru E,Medl M,et al.Preoperative CA 125:An independent prognostic factor in patients with stage I epithelial ovarian cancer[J].Obstet Gynecol,1995,86(2):259-264.
  • 7Kraemer S,Jaeger WH,Lang N.Growth regulation effects of gonadotropin induced steroidogenic response in human ovarian cancer[J].Anticancer Res,2001,21(3):2005-2010.
  • 8Koji T,Fumitaka K,Kiyosumi S,et al.Clinical value of CA125,CA19-9,CEA,CA72-4 and TPA in borderline ovarian tumor[J].Gynecologic Oncol,1996,62(1):67-72.
  • 9Digant G,Christopher GL.Role of CA125 in predicting ovarian cancer survival-a review of the epidemiological literature[J].J Ovarian Res,2009,9(2):13.
  • 10Munstedt K,Steen J,Knauf AG,et al.Steroid hormone receptors and long term survival in invasive ovarian cancer[J].Cancer,2000,89(8):783-791.

共引文献41

同被引文献201

  • 1钱其军,张琪.肿瘤靶向治疗的现状和展望[J].中国肿瘤生物治疗杂志,2006,13(4):239-242. 被引量：7
  • 2Feng Li,Benjamin Tiede,Joan Massague,Yibin Kang.Beyond tumorigenesis: cancer stem cells in metastasis[J].Cell Research,2007,17(1):3-14. 被引量：86
  • 3陈运贤,朱小玉.肿瘤治疗新目标——肿瘤干细胞[J].中国肿瘤,2007,16(7):518-520. 被引量：3
  • 4Mani SA, Guo WJ, Liao M J, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells [ J ]. Cell, 2008, 133(4) : 704-715.
  • 5Bracke ME, Vanhoecke B, Derycke L, et al. Plant polypheno- lics as anti-invasive cancer agents [ J ]. Anticancer Agents Med Chem, 2008, 8(2) : 171-185.
  • 6Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma [J]. Cancer Cell, 2004, 5(5): 423-428.
  • 7Wang J, Guo LP, Chert LZ, et al. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line[J]. Cancer Res, 2007, 67(8): 3716-3724.
  • 8Martens D J, Tropepe V, van Der Kooy D. Separate proliferation kinetics of fibroblast growth factor-responsive and epidermal growth factor-responsive neural stem cells within the embryonic forebrain germinal zone[ J]. J Neurosci, 2000, 20 (3) : 1085- 1095.
  • 9Reynolds BA, Weiss S. Clonal and population analyses demon- strate that anEGF-responsive mammalian embryonic CNS precur- sor is a stem cell[J]. Dev Biol, 1996, 175(1) : 1-13.
  • 10Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro prop- agation of tumorigenic breast cancer cells with stem/progenitor cell properties[ J]. Cancer Res, 2005, 65 ( 13 ) : 5506-5511.

引证文献8

二级引证文献26

医学研究生学报
2012年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部